Skip to main content

Angeliq

NDC 50419-483 · Bayer HealthCare Pharmaceuticals Inc.

Generic namedrospirenone and estradiol
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)ESTRADIOL, DROSPIRENONE
Strength.5; 1 mg/1; mg/1
Pharmacologic classEstradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]
Marketing categoryNDA

Packages

50419-483-03 — 3 BLISTER PACK in 1 CARTON (50419-483-03) / 28 TABLET, FILM COATED in 1 BLISTER PACK (50419-483-01)

50419-483-72 — 1 BLISTER PACK in 1 CARTON (50419-483-72) / 14 TABLET, FILM COATED in 1 BLISTER PACK (50419-483-71)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-8003 — Estradiol and Norethindrone Acetate, 50090-8004 — Estradiol and Norethindrone Acetate, 50419-451 — Estradiol, 50419-452 — Estradiol, 50419-453 — Estradiol, 50419-454 — Estradiol, 50419-455 — estradiol, 50419-456 — Estradiol, 50419-459 — Estradiol, 50419-482 — drospirenone and estradiol, 50419-491 — Estradiol and Levonorgestrel, 50742-657 — Estradiol and Norethindrone Acetate, 50742-658 — Estradiol and Norethindrone Acetate, 51655-227 — Estradiol, 51655-229 — Estradiol, 51655-860 — ESTRADIOL, 51991-474 — Estradiol and Norethindrone Acetate, 51991-623 — Estradiol and Norethindrone Acetate, 53746-226 — Estradiol, 54348-701 — ESTRADIOL, +258 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels